Carcinoid heart in neuroendcrine tumor – Experience of medical departement oncology Oran, Algeria

#4245

Introduction: The carcinoid heart is present in approximately 20% of cases at the diagnosis of carcinoid dyndrome in neuroendocrine tumors, and will occur in approximately 50% of patients during follow-up. The consequence is the appearance of stenosing and/or leaking valvular diseases, responsible, eventually, right or left ventricular dysfunction and severe heart failure. Only surgical valve replacement treatment seems to be able to improve the prognosis, but at the cost of significant perioperative morbidity and mortality.

Aim(s): To describe the clinical and therapeutic aspects of patients with a carcinoid heart disease.

Materials and methods: We report a series of 17 patients treated at the medical oncology department of EHU Oran collected between 2016 and 2021 for a neuroendocrine tumor on a carcinoid heart.

Conference:

Presenting Author: Kaid M

Authors: Kaid M, Bengueddach A, Bennaoum A, Kehili H, Bereksi-Reguig F,

Keywords: carcinoid heart disease, somatostatin,